Lincoln Pharmaceuticals Ltd Financial Overview
Lincoln Pharmaceuticals Ltd's market cap is currently ₹9.75B. The company's EPS TTM is ₹9.977; its P/E ratio is 12.18; and it has a dividend yield of 0.37%. Lincoln Pharmaceuticals Ltd is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
